Your browser doesn't support javascript.
loading
Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
Cid Ruzafa, J; Paczkowski, R; Boye, K S; Di Tanna, G L; Sheetz, M J; Donaldson, R; Breyer, M D; Neasham, D; Voelker, J R.
Afiliación
  • Cid Ruzafa J; Evidera, London, UK.
  • Paczkowski R; Eli Lilly and Company, Indianapolis, IN, USA.
  • Boye KS; Eli Lilly and Company, Indianapolis, IN, USA.
  • Di Tanna GL; Evidera, London, UK.
  • Sheetz MJ; Eli Lilly and Company, Indianapolis, IN, USA.
  • Donaldson R; Evidera, London, UK.
  • Breyer MD; Eli Lilly and Company, Indianapolis, IN, USA.
  • Neasham D; Evidera, London, UK.
  • Voelker JR; Eli Lilly and Company, Indianapolis, IN, USA.
Int J Clin Pract ; 69(8): 871-82, 2015 Aug.
Article en En | MEDLINE | ID: mdl-26011029
AIMS: To examine the rates of diabetic kidney disease (DKD) progression and associated factors, we undertook a study of estimated glomerular filtration rate (eGFR) in a historical cohort of UK primary care patients with type 2 diabetes mellitus (T2DM) and associated DKD from the Clinical Practice Research Datalink. METHODS: Our eligible population were patients with definitive T2DM from a recorded diagnostic code with either a diagnosis of chronic kidney disease (CKD) or renal function test values and renal abnormalities consistent with a CKD diagnosis, identified between 1 October 2006 and 31 December 2011. Only patients with albuminuria results reported in mg/l were used for the longitudinal statistical analyses of the eGFR rate of change using multilevel models. RESULTS: We identified 111,030 patients with T2DM. Among them 58.6% (95% confidence interval (CI): 58.3-58.9) had CKD and 37.2% (95% CI: 36.9-37.5%) had presumed DKD at baseline. Only 19.4% of patients had urinary albumin test results expressed as mg/l in the year prior to index date. Almost two-thirds (63.8%) of patients with T2DM and presumed DKD received prescriptions for angiotensin-converting enzyme (ACE) inhibitors or angiotensin type 1 receptor blockers (ARB) or both. Time-dependent variables that predict subsequent eGFR decline include increased albuminuria, time from index date and older age. CONCLUSION: Only a minority of diabetic patients with DKD had quantitative albuminuria assessments. The relatively low proportion of DKD patients with ACEi or ARB prescriptions suggests a gap between healthcare practice and available scientific evidence during the study period. Increased albuminuria and older age were the most consistent predictors of subsequent eGFR decline.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Tasa de Filtración Glomerular / Fallo Renal Crónico Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Clin Pract Asunto de la revista: MEDICINA Año: 2015 Tipo del documento: Article Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Tasa de Filtración Glomerular / Fallo Renal Crónico Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Clin Pract Asunto de la revista: MEDICINA Año: 2015 Tipo del documento: Article Pais de publicación: India